(19)

(11)

EP 4 580 619 A1

(12)

(43) Date of publication: 09.07.2025 Bulletin 2025/28 (21) Application number: 23861306.1 (22) Date of filing: 31.08.2023

(51) International Patent Classification (IPC):  A61K 31/395(2006.01) A61K 31/4162(2006.01) A61K 31/44(2006.01) A61K 31/33(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/444; A61K 31/4174; A61K 9/006; A61K 9/205   C-Sets: A61K 31/444, A61K 2300/00; A61K 31/4174, A61K 2300/00; (86) International application number: PCT/US2023/031731 (87) International publication number: WO 2024/050028 (07.03.2024 Gazette 2024/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 31.08.2022 US 202263402855 P (71) Applicant: BioXcel Therapeutics, Inc. New Haven, CT 06511 (US)	(72) Inventors: DE VIVO, Michael New Haven, Connecticut 06511 (US) SETH, Subhendu Gurgaon, Haryana 122002 (IN) DHULL, Dinesh Kumar Gurgaon, Haryana 122002 (IN) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)